Epigenetic and transcriptomic analysis revealed ceRNA regulatory network in glioblastoma multiforme
Open Access
- 9 October 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1-12
Abstract
Glioblastoma multiforme (GBM) is one of the most common cancers among malignant tumors, and extensive evidence suggests that the prognosis of various human cancers is associated with DNA methylation. Therefore, we analyzed potential GBM prognostic biomarkers by combining GBM methylation sequencing data and transcriptome sequencing data. Biostatistical analysis of the expression of three RNA types (long non-coding RNA, microRNA, and mRNA) from The Cancer Genome Atlas (TCGA) was performed to determine the correlation between NACAD and GBM prognosis. Additionally, we predicted and validated a competitive endogenous RNA (ceRNA) regulatory network associated with epigenetic DNA methylation modifications. The ceRNA regulatory network (DCTN1-AS1–hsa-let-7a-5p–NACAD) was found to be related to overall survival (OS) and disease-specific survival (DSS) of GBM. Furthermore, we identified NACAD as an independent prognostic factor for both GBM OS and DSS. In summary, comprehensive analysis of methylation and transcriptome data led to the identification of genes and pathways in different GBM subtypes, highlighting prognostic genes and ceRNA regulatory networks, and proposing potential candidates.Keywords
Funding Information
- PhD research startup foundation of the Third Affiliated Hospital of Zhengzhou University (BS20230111)
This publication has 35 references indexed in Scilit:
- Epidemiologic and Molecular Prognostic Review of GlioblastomaCancer Epidemiology, Biomarkers & Prevention, 2014
- Impact of 5‐aza‐2′‐deoxycytidine and epigallocatechin‐3‐gallate for induction of human regulatory T cellsImmunology, 2014
- Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigenNature Immunology, 2013
- Innate and adaptive immune cells in the tumor microenvironmentNature Immunology, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Unraveling the Glioma Epigenome—From Molecular Mechanisms to Novel Biomarkers and Therapeutic TargetsBrain Pathology, 2011
- MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaNeuro-Oncology, 2009
- IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary GlioblastomasClinical Cancer Research, 2009
- Epigenetic mechanisms in glioblastoma multiformeSeminars in Cancer Biology, 2009
- Cytosolic NADP+-dependent Isocitrate Dehydrogenase Plays a Key Role in Lipid MetabolismJournal of Biological Chemistry, 2004